Skip NavigationSkip to Content

Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: Stimulation by the viral nucleocapsid protein

  1. Author:
    Carteau, S.
    Gorelick, R. J.
    Bushman, F. D.
  2. Author Address

    Bushman FD Salk Inst, Infect Dis Lab 10010 N Torrey Pines Rd La Jolla, CA 92037 USA Salk Inst, Infect Dis Lab La Jolla, CA 92037 USA NCI, AIDS Vaccine Program, SAIC Frederick, Frederick Canc Res & Dev Ctr Frederick, MD 21702 USA
    1. Year: 1999
  1. Journal: Journal of Virology
    1. 73
    2. 8
    3. Pages: 6670-6679
  2. Type of Article: Article
  1. Abstract:

    Integration of retroviral cDNA involves coupled joining of the two ends of the viral genome at precisely spaced positions in the host cell DNA. Correct coupled joining is essential for viral replication, as shown, for example, by the finding that viral mutants defective in coupled joining are defective in integration and replication. To date reactions with purified human immunodeficiency virus type 1 (HIV-1) integrase protein in vitro have supported mainly uncoupled joining of single cDNA ends. We have analyzed an activity stimulating coupled joining present in HIV-1 virions, which led to the finding that the HIV-1 nucleocapsid (NC) protein can stimulate coupled joining more than 1,000-fold under some conditions. The requirements for stimulating coupled joining were investigated in assays with mutant NC proteins, revealing that mutations in the zinc finger domains can influence stimulation of integration. These findings (i) provide a means for assembling more authentic integrase complexes for mechanistic studies, (ii) reveal a new activity of NC protein in vitro, (iii) indicate a possible role for NC in vivo, and (iv) provide a possible method for identifying a new class of inhibitors that disrupt coupled joining. [References: 59]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.

Your Recently Viewed Publications:

Next generation DNA vaccines for HIV-1
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel